Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod.
Previous reports of cutaneous neoplastic lesions secondary to Fingolimod treatment among multiple sclerosis patients. Reporting a case of cutaneous large cell lymphoma in a multiple sclerosis patient during Fingolimod treatment. Case study. Our patient developed CD30+ cutaneous large cell lymphoma two years after initiation of Fingolimod treatment and her symptoms regressed following the cessation of treatment. This report indicates that cutaneous lymphoid neoplasms should be considered a possible side effect among patients receiving Fingolimod.